339 related articles for article (PubMed ID: 28914715)
21. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract][Full Text] [Related]
22. Solid Variant of Adenoid Cystic Carcinoma: Difficulties in Diagnostic Recognition.
Ben Salha I; Bhide S; Mourtzoukou D; Fisher C; Thway K
Int J Surg Pathol; 2016 Aug; 24(5):419-24. PubMed ID: 27069025
[TBL] [Abstract][Full Text] [Related]
23. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
[TBL] [Abstract][Full Text] [Related]
24. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
[TBL] [Abstract][Full Text] [Related]
25. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland.
Freier K; Flechtenmacher C; Walch A; Devens F; Mühling J; Lichter P; Joos S; Hofele C
Oral Oncol; 2005 Oct; 41(9):934-9. PubMed ID: 16054424
[TBL] [Abstract][Full Text] [Related]
26. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
[TBL] [Abstract][Full Text] [Related]
27. Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.
Ouyang DQ; Liang LZ; Ke ZF; Zheng GS; Weng DS; Yang WF; Su YX; Liao GQ
Head Neck; 2017 Jun; 39(6):1145-1154. PubMed ID: 28230926
[TBL] [Abstract][Full Text] [Related]
28. Primary pulmonary adenoid cystic carcinoma: clinicopathological analyses of 12 cases.
Qing S; Zhou K; Liu X; Li X; Deng F; Ma Y
Int J Clin Exp Pathol; 2015; 8(6):7619-26. PubMed ID: 26261681
[TBL] [Abstract][Full Text] [Related]
29. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
[TBL] [Abstract][Full Text] [Related]
30. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
[TBL] [Abstract][Full Text] [Related]
31. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
32. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
33. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
Xie M; Wei S; Wu X; Li X; You Y; He C
Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical studies of S-100 protein alpha and beta subunits in adenoid cystic carcinoma of salivary glands.
Mori M; Kasai T; Yuba R; Chomette G; Auriol M; Vaillant JM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(2):115-23. PubMed ID: 1977233
[TBL] [Abstract][Full Text] [Related]
35. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study.
Bonaparte JP; Hart R; Trites J; Taylor MS
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):642-8. PubMed ID: 19128670
[TBL] [Abstract][Full Text] [Related]
36. Anti-NOTCH1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis.
Li R; Hu Z; Qiao Q; Zhou D; Sun M
Toxicol Appl Pharmacol; 2024 Mar; 484():116825. PubMed ID: 38253083
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localization of MAM-3 and MAM-6 antigens in adenoid cystic carcinoma.
Yamada K; Kunikata M; Mori M; Chomette G; Auriol M; Vaillant JM; Tubura A; Morii S; Hilgers J
J Oral Pathol Med; 1991 Feb; 20(2):57-63. PubMed ID: 1849991
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.
Hirvonen K; Bäck L; Haglund C; Leivo I; Jouhi L; Mäkitie AA; Hagström J
Tumour Biol; 2016 Aug; 37(8):10959-64. PubMed ID: 26888781
[TBL] [Abstract][Full Text] [Related]
39. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.
Tian Z; Li L; Zhang CY; Gu T; Li J
J Oral Pathol Med; 2016 Oct; 45(9):698-703. PubMed ID: 26711587
[TBL] [Abstract][Full Text] [Related]
40. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.
Kluk MJ; Ashworth T; Wang H; Knoechel B; Mason EF; Morgan EA; Dorfman D; Pinkus G; Weigert O; Hornick JL; Chirieac LR; Hirsch M; Oh DJ; South AP; Leigh IM; Pourreyron C; Cassidy AJ; Deangelo DJ; Weinstock DM; Krop IE; Dillon D; Brock JE; Lazar AJ; Peto M; Cho RJ; Stoeck A; Haines BB; Sathayanrayanan S; Rodig S; Aster JC
PLoS One; 2013; 8(6):e67306. PubMed ID: 23825651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
